These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 12354999
1. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver. Arbab AS, Ichikawa T, Sou H, Araki T, Nakajima H, Ishigame K, Yoshikawa T, Kumagai H. Radiology; 2002 Oct; 225(1):151-8. PubMed ID: 12354999 [Abstract] [Full Text] [Related]
2. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. Kim JH, Kim MJ, Suh SH, Chung JJ, Yoo HS, Lee JT. J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899 [Abstract] [Full Text] [Related]
3. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, Kreft B, Schild H. Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708 [Abstract] [Full Text] [Related]
4. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, Katahira K, Takahashi M. AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [Abstract] [Full Text] [Related]
5. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging. Lee JM, Kim CS, Youk JH, Lee MS. Korean J Radiol; 2003 Jun; 4(1):9-18. PubMed ID: 12679629 [Abstract] [Full Text] [Related]
6. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners. Limanond P, Raman SS, Sayre J, Lu DS. J Magn Reson Imaging; 2004 Oct; 20(4):640-7. PubMed ID: 15390231 [Abstract] [Full Text] [Related]
7. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences. Kanematsu M, Itoh K, Matsuo M, Maetani Y, Ametani F, Kondo H, Kato H, Hoshi H. J Magn Reson Imaging; 2001 Feb; 13(2):249-57. PubMed ID: 11169831 [Abstract] [Full Text] [Related]
8. Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging. Mori K, Scheidler J, Helmberger T, Holzknecht N, Schauer R, Schirren CA, Bittmann I, Dugas M, Reiser M. AJR Am J Roentgenol; 2002 Oct; 179(4):1045-51. PubMed ID: 12239063 [Abstract] [Full Text] [Related]
12. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. Paley MR, Mergo PJ, Torres GM, Ros PR. AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267 [Abstract] [Full Text] [Related]
13. Hepatic MR imaging using ferumoxides: prospective evaluation with surgical and intraoperative sonographic confirmation in 25 cases. Raman SS, Lu DS, Chen SC, Sayre J, Eilber F, Economou J. AJR Am J Roentgenol; 2001 Oct; 177(4):807-12. PubMed ID: 11566677 [Abstract] [Full Text] [Related]
14. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging. Schima W, Saini S, Echeverri JA, Hahn PF, Harisinghani M, Mueller PR. Radiology; 1997 Feb; 202(2):389-93. PubMed ID: 9015063 [Abstract] [Full Text] [Related]
15. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis]. Stroszczynski C, Gaffke G, Gretschel S, Rambow A, Jost D, Schlecht I, Schneider U, Schicke B, Hohenberger P, Gebauer B, Felix R. Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106 [Abstract] [Full Text] [Related]